Overview

A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Latanoprost
Timolol
Travoprost